Kamil Ali-Jackson | CLO and Corporate Secretary |
Neal Walker | President and CEO |
Brett Fair | Chief Commercial Officer |
Stuart D. Shanler | Chief Scientific Officer |
Frank Ruffo | Treasurer and Chief Financial Officer |
David Gordon | CMO |
Louise Chen | Cantor Fitzgerald & Co. |
Tim Lugo | William Blair & Company |
Adnan Butt | Guggenheim Securities |
Donald Ellis | JMP Securities |
David Steinberg | Jefferies |
Good day, ladies and gentlemen and welcome to the Q2 2018 Aclaris Therapeutics, Incorporated Earnings Conference Call. At this time all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions].
As a reminder, this conference call maybe recorded.